Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas
- 16 May 2002
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 80 (2) , 105-110
- https://doi.org/10.1002/jso.10106
Abstract
Background and Objectives Matrix metalloproteinases (MMPs) are known to play an important role in carcinoma cell invasion and hematogenous metastasis by mediating the degradation of the extracellular matrix. Methods We investigated the relationship between MMP‐2 and ‐9 enzymatic activities and liver metastases in human pancreatic and colon carcinomas, using xenograft tumors in nude mice. Results We found that type IV collagenase activity in pancreatic and colon carcinomas with liver metastases was significantly higher than in pancreatic and colon carcinomas without liver metastases. Gelatin zymography showed the presence of gelatinolytic activity bands at Mr 92,000 and 72,000, indicating MMP‐9 and MMP‐2, respectively. MMP‐2 and ‐9 expression levels in pancreatic and colon carcinomas with liver metastases were higher than in pancreatic and colon carcinomas without liver metastases. TIMP‐2 levels in pancreatic and colon carcinomas with liver metastases were also higher than in those without liver metastases. Conclusions MMP‐2 and MMP‐9 expression in primary tumors is associated with liver metastases in pancreatic and colon carcinomas. In addition, the balance of activity between MMP‐2, MMP‐9, and TIMP‐2 may be relevant to carcinoma invasion and metastasis, including liver metastases in pancreatic and colon carcinoma. J. Surg. Oncol. 2002;80:105–110.Keywords
This publication has 25 references indexed in Scilit:
- Matrix metalloproteinases, their tissue inhibitors and colorectal cancer stagingBritish Journal of Surgery, 2000
- Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancerJournal of Surgical Oncology, 2000
- In situ detection of matrix metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasisJournal of Hepatology, 1997
- Stromal Expression of MMP‐9 and Urokinase Receptor Is Inversely Associated with Liver Metastasis and with Infiltrating Growth in Human Colorectal Cancer: A Novel Approach from Immune/Inflammatory AspectJapanese Journal of Cancer Research, 1997
- Expression and in‐situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancerInternational Journal of Cancer, 1995
- Tumor Cell Interactions with the Extracellular Matrix During Invasion and MetastasisAnnual Review of Cell Biology, 1993
- Activation of TIMP-2/progelatinase a complex by stromelysinBiochemical and Biophysical Research Communications, 1992
- Influence of Organ Environment on Extracellular Matrix Degradative Activity and Metastasis of Human Colon Carcinoma CellsJNCI Journal of the National Cancer Institute, 1990
- Inhibition of Collagenolytic Activity and Metastasis of Tumor Cells by a Recombinant Human Tissue Inhibitor of MetalloproteinasesJNCI Journal of the National Cancer Institute, 1990
- Metastatic potential correlates with enzymatic degradation of basement membrane collagenNature, 1980